Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):552–561. doi: 10.1097/QAI.0000000000002067

Table 5.

HIV care cascades for participants with HIV alone and combined HIV/HTN based on the definitions presented in Table 1

HIV cascade for HIV alone (n=1431) HIV cascade for HIV/HTN (n=218)
Cascade step Freq. (n) Denominator % CI Freq. (n) Denominator % CI p value
Initiated 1408 1431 98.4 97.6 – 99.0 217 218 99.5 97.5 – 99.9 0.2075
Retained 1005 1408 71.4 68.9 – 73.7 143 217 65.9 59.2 – 72.2 0.2205
Monitored 1005 1005 100.0 99.6 −100.0 143 143 100.0 97.5 – 100.0 0.1660
Controlled 906 1005 90.2 88.1 – 91.9 131 143 91.6 85.8 – 95.6 0.4707

PLHIV=persons living with HIV, ART=Antiretroviral therapy, %=percentage, CI=95% confidence interval